According to a new report published by UnivDatos Markets Insights, the Carbetocin market was valued at USD 170 million in 2021 & is expected to grow at a CAGR of 8% from 2022-2030. The analysis has been segmented into Type (Original Drug and Generic Drug); End-User (Hospitals, Clinics, and Others); Region/Country.
Click here to view the Report Description & TOC - https://univdatos.com/report/carbetocin-market/
The carbetocin market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the carbetocin market. The carbetocin market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing market growth. Furthermore, this statistical market research repository examines and estimates the carbetocin market at the global and regional levels.
Download a Sample Pages - https://univdatos.com/get-a-free-sample-form-php/?product_id=38919
Key Market Dynamics
Postpartum hemorrhage (PPH) is defined as excessive bleeding after delivery, and it is one of the leading causes of maternal mortality worldwide. PPH can occur due to various reasons, including uterine atony, retained placenta, trauma during delivery, and coagulation disorders. It can be life-threatening and requires prompt medical intervention to prevent maternal morbidity and mortality. The incidence of PPH has been increasing globally is the major reason driving the market for carbetocin. For instance, as per the WHO, approximately 14 million women develop PPH each year, and approximately 70,000 maternal deaths occur worldwide. Even if the woman survives, emergency surgery is often needed to control the bleeding, which can result in lifelong reproductive problems.
Download a Sample Pages - https://univdatos.com/get-a-free-sample-form-php/?product_id=38919
COVID-19 Impact
The COVID-19 pandemic has also affected the demand for carbetocin. The pandemic has caused a significant reduction in the number of women giving birth in hospitals, as many pregnant women have opted for home births or delayed their pregnancies due to concerns about the virus. This reduction in demand for carbetocin has further exacerbated the supply chain disruptions and has led to a decrease in sales of the drug.
· Based on type, the market is segmented into original drug and generic drug. As per our analysis, the generic drug segment is expected to grow at a higher CAGR during the forecast period.
· Based on the end-user, the market is segmented into hospitals, clinics, and others. As per our analysis, the hospitals held the dominant share in 2021.
Have a Look at the Chapters - https://univdatos.com/report/carbetocin-market/
Carbetocin Market Geographical Segmentation Includes:
· North America (U.S., Canada, and the Rest of North America)
· Europe (Germany, UK, Spain, Italy, France, Rest of Europe)
· Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific)
· Rest of the World
Asia Pacific is expected to grow with the highest CAGR Carbetocin market during the forecast period due to its large population and increasing incidences of drug toxicity which increases the demand for drug safety and toxicity testing. For instance, According to National Health Mission (NHM) guidelines, PPH is the leading cause of death for women in childbirth in India, with 38% of maternal deaths caused by PPH.
Competitive Landscape
The degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the carbetocin market. The major players have been analyzed by using research methodologies such as Porter’s Five Forces Analysis for getting insight views on global competition.
Recent Developments:
· In 2021, Abbott Laboratory launched a single-dose formulation of carbetocin to prevent post partem hemorrhage.
· In 2021, BSV launched Carbetocin to improve the prevention of Post-Partum Haemorrhage (PPH).
Key questions resolved through this analytical market research report include:
• What are the latest trends, new patterns, and technological advancements in the carbetocin market?
• Which factors are influencing the carbetocin market over the forecast period?
• What are the global challenges, threats, and risks of the carbetocin market?
• Which factors are propelling and restraining the carbetocin market?
• What are the demanding global regions of the carbetocin market?
• What will be the global market size in the upcoming years?
• What are the crucial market acquisition strategies and policies applied by global companies?
• What are the descriptive profiles of key companies along with their SWOT analysis?
We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature and geography. Please let us know If you have any custom needs.